Cervical cancer Clinical Trials

Recruiting cervical cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat cervical cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting cervical cancer studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting cervical cancer trials

Within

Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)

for Cervical Cancer Screening

Sponsor: Boston Medical Center

Sex: Female·Age: 21 - 65

Code: NCT07226037

Breast and Cervical Cancer Stigma in Rwanda

for Breast Cancer

Sponsor: Dana-Farber Cancer Institute

Sex: Female·Age: 18+

Code: NCT07663006

Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies

for Gynecologic Cancer

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: Female·Age: 18 - 99

Code: NCT07702721

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

for Advanced Cervical Carcinoma

1 site in St Louis

Sponsor: Washington University School of Medicine

Sex: All·Age: 18+

Code: NCT05521997·Phase 2

Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers

for HIV (Human Immunodeficiency Virus)

Sponsor: Shenzhen Third People's Hospital

Sex: All·Age: 18+

Code: NCT07696169

Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing

for Cervical Cancer

Sponsor: Sakarya University

Sex: Female·Age: 18 - 60·Accepts healthy volunteers

Code: NCT07620795

COQ10 and Vitamin E for Off-Target Radiation Toxicity

for Prostate Cancer

1 site in Omaha

Sponsor: University of Nebraska

Sex: All·Age: 19+

Code: NCT07668284·Phase 1, Phase 2

My Self-Sampling for HPV Awareness, Results, and Empowerment

for Cervical Cancer

Sponsor: Daisy Le

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07296159

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

for Human Immunodeficiency Virus (HIV)

2 sites incl. Atlanta

Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All·Age: 25 - 49·Accepts healthy volunteers

Code: NCT07520188

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

for Breast Cancer

5 sites incl. Los Angeles

Sponsor: Regor Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT07524322·Phase 1

Apply to this trial

PRIORITY Study in Cervical Cancer

for Cervical Cancer

Sponsor: Pontificia Universidad Catolica de Chile

Sex: Female·Age: 30 - 65·Accepts healthy volunteers

Code: NCT07593066

A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

for Solid Tumor

Sponsor: Huahui Health

Sex: All·Age: 18 - 75

Code: NCT07623369·Phase 1

Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer

for Cervical Cancer

Sponsor: Hunan Cancer Hospital

Sex: Female·Age: 18 - 75

Code: NCT07627620·Phase 2

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

for Cervical Cancer

Sponsor: Zhejiang Cancer Hospital

Sex: Female·Age: 18+

Code: NCT07673211

QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer

for Cervical Cancer

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Sex: Female·Age: 18 - 65

Code: NCT07617818·Phase 2

Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

for Gastric Cancer

Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07676461

Apply to this trial

Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial

for Cervical Cancer

Sponsor: Obstetrics & Gynecology Hospital of Fudan University

Sex: Female·Age: 18 - 75

Code: NCT07649174·Phase 2

Intervention of CAR-T Against Cervical Cancer

for Cervical Cancer

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: Female·Age: 18 - 70

Code: NCT03356795·Phase 1, Phase 2

Apply to this trial

Engineered Immune Effectors Against Cervical Cancer

for Cervical Cancer

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: Female·Age: 10 - 80

Code: NCT03362619·Phase 1, Phase 2

Apply to this trial

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

for Cervical Cancer

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 25 - 49

Code: NCT06850402

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

for Human Papillomavirus (HPV)

Sponsor: University of California, San Diego

Sex: Female·Age: 25+

Code: NCT07576842

MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer

for Cervical Cancer

Sponsor: Xiaorong Hou

Sex: Female·Age: 18 - 75

Code: NCT07584161

Adaptive Radiotherapy for Safe Hypofractionation

for Cancer

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All·Age: All ages

Code: NCT07516210·Phase 2

Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

for Cervical Cancer

Sponsor: Beni-Suef University

Sex: Female·Age: 30 - 60

Code: NCT07597083

Apply to this trial

Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

for Cervical Cancer

Sponsor: University Medical Center Groningen

Sex: Female·Age: 18+

Code: NCT07645625·Phase 4

Apply to this trial

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

for Cervical Cancer

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Sex: All·Age: 18+

Code: NCT07497074·Phase 2

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

for Clear Cell Renal Cell Cancer (ccRCC)

Sponsor: Peking University First Hospital

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07557225

Apply to this trial

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

for Cervical Cancer

1 site in St Louis

Sponsor: Washington University School of Medicine

Sex: Female·Age: 25 - 65·Accepts healthy volunteers

Code: NCT07453459

Apply to this trial

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

for Cervical Cancer

1 site in Cincinnati

Sponsor: University of Cincinnati

Sex: Female·Age: 18+

Code: NCT07447895

Apply to this trial

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

for Cervical Cancer

Sponsor: Jin LI

Sex: Female·Age: 18 - 75

Code: NCT07466901

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

for Gynaecologic Cancer

5 sites incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: Female·Age: 18+

Code: NCT07415681·Phase 2

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

for Breast Cancer

1 site in Pasadena

Sponsor: Kaiser Permanente

Sex: All·Age: 21 - 45

Code: NCT07406087

Apply to this trial

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

for Cervical Cancer

Sponsor: Uganda Cancer Institute

Sex: Female·Age: 18+

Code: NCT07276360·Phase 2

Apply to this trial

Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer

for Cervical Cancer

Sponsor: Fundacion Clinic per a la Recerca Biomédica

Sex: Female·Age: 18+

Code: NCT07412873·Phase 4

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

for Cervical Cancer

Sponsor: Kortuc, Inc.

Sex: Female·Age: 18+

Code: NCT05570422·Phase 1

Apply to this trial

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

for Breast Cancer

1 site in Milwaukee

Sponsor: Medical College of Wisconsin

Sex: All·Age: 65+

Code: NCT07227077

Apply to this trial

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for Castration-Resistant Prostate Cancer (CRPC)

4 sites incl. Dothan

Sponsor: Radiopharm Theranostics, Ltd

Sex: All·Age: 18+

Code: NCT07189871·Phase 1, Phase 2

Apply to this trial

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

for HIV Infections

Sponsor: Columbia University

Sex: Female·Age: 25+·Accepts healthy volunteers

Code: NCT07225530

Apply to this trial

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

for Uterine Neoplasms

Sponsor: Asan Medical Center

Sex: Female·Age: All ages

Code: NCT07382505

Distance-Based Exercise to Preserve Function and Prevent Disability

for Localized Malignant Solid Neoplasm

18 sites incl. Dublin

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT07059884

Apply to this trial

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

for Cervical Cancer

Sponsor: University of California, Irvine

Sex: Female·Age: 25 - 50

Code: NCT07209917

Apply to this trial

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

for Cervical Cancer

Sponsor: Zheng Min

Sex: Female·Age: 18 - 65

Code: NCT07348861·Phase 2

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

for Cervical Cancer

Sponsor: Zhongnan Hospital

Sex: Female·Age: 18 - 75

Code: NCT07363330·Phase 2

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

for Cervical Cancer

Sponsor: Fujian Cancer Hospital

Sex: Female·Age: 18+

Code: NCT07256236·Phase 2

Apply to this trial

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

for Cervical Cancer

Sponsor: Centre Hospitalier Intercommunal Creteil

Sex: All·Age: 25 - 65

Code: NCT06527456

Apply to this trial

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for Cervical Cancer

18 sites incl. Miami Beach

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT07216703·Phase 3

Apply to this trial

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

for Cervical Cancer

Sponsor: Far Eastern Memorial Hospital

Sex: Female·Age: All ages·Accepts healthy volunteers

Code: NCT07385976

HYPOfractionated RadioTherapy in Cervical Cancer

for Cervical Cancer Squamous Cell

Sponsor: All India Institute of Medical Sciences

Sex: Female·Age: 18 - 65

Code: NCT07625943

Apply to this trial

Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy

for Cervical Cancer

Sponsor: Obstetrics & Gynecology Hospital of Fudan University

Sex: Female·Age: All ages

Code: NCT07318701

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

for Peripheral Neuropathy

Sponsor: Taipei Veterans General Hospital, Taiwan

Sex: Female·Age: 65+

Code: NCT07362147

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

for Persistent Isolated Chemotherapy-Induced Thrombocytopenia

Sponsor: Peking University People's Hospital

Sex: All·Age: 18+

Code: NCT07586826·Phase 2

Apply to this trial

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

for Cervical Cancer

1 site in Gainesville

Sponsor: University of Florida

Sex: Female·Age: 18 - 89

Code: NCT07214584

Apply to this trial

Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

for Cervical Cancer

Sponsor: Samsung Medical Center

Sex: Female·Age: 20+

Code: NCT07439497·Phase 2

Apply to this trial

Serplulimab for Locally Advanced Cervical Cancer

for Cervical Cancer

Sponsor: Tianjin Medical University Cancer Institute and Hospital

Sex: Female·Age: 18 - 75

Code: NCT07340489·Phase 2

Apply to this trial

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

for Esophageal Cancer

Sponsor: Anhui Provincial Hospital

Sex: All·Age: 18 - 75

Code: NCT06760676·Phase 1

Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

for Cervical Cancer

Sponsor: Kenyatta National Hospital

Sex: Female·Age: 25 - 49·Accepts healthy volunteers

Code: NCT07050745

Apply to this trial

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

for Cervical Cancer

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.

Sex: Female·Age: 18 - 75

Code: NCT07230626·Phase 3

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

for Cervical Cancer

1 site in Boston

Sponsor: Boston University Charles River Campus

Sex: Female·Age: 18+

Code: NCT06182241

Apply to this trial

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

for Non Small Cell Lung Cancer

11 sites incl. San Francisco

Sponsor: Rondo Therapeutics

Sex: All·Age: 18+

Code: NCT07218003·Phase 1

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

for Cervical Cancer

3 sites incl. Little Rock

Sponsor: Precigen, Inc

Sex: All·Age: 18+

Code: NCT06157151·Phase 2

Apply to this trial

Cervical cancer clinical trials — common questions

Are cervical cancer clinical trials free to join?

Yes. Participating in a cervical cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a cervical cancer clinical trial?

Each cervical cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a cervical cancer trial near me?

Use the location controls above. We'll show recruiting cervical cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many cervical cancer trials are recruiting right now?

We're currently tracking roughly 87 recruiting cervical cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Cervical cancer trials by city

Los Angeles, CA Birmingham, AL Denver, CO Chicago, IL Duarte, CA San Francisco, CA Beverly Hills, CA Boston, MA Cincinnati, OH La Jolla, CA Orlando, FL Aurora, CO

Related specialties

Oncology Gynecologic oncology Women's health